Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafuspToulsie Ramtohul, Manuel Alves Rodrígues, Gaëlle Pierron et al.|Diagnostic and Interventional Imaging|2026Cited by 1
MRI-derived tumor burden and growth rate as translational biomarkers: Head-to-head comparison with RECIST and ctDNA in tebentafusp-treated metastatic uveal melanoma.Toulsie Ramtohul, Manuel Rodrigues, Xavier-Louis Jasawant et al.|Journal of Clinical Oncology|2026Cited by 0